herpes zoster vaccine
AssetAlso Herpes Zoster Vaccine, Live, GSK 1437173A, GSK1437173A
Live attenuated vaccine induces immunity against varicella-zoster virus to prevent herpes zoster.
- Stage
- Phase 3
- Modality
- Vaccine
- Target
- Not known
- 3
- Indications
- 5
- Trials
- 2
- Developers
Indications
3Herpes zoster
Phase 3, Completed, NCT02075515, clinicaltrials.gov, 11 Oct 2026
Herpes zoster vaccine
Phase 3, Completed, NCT02075515, clinicaltrials.gov, 11 Oct 2026
Prevention of herpes zoster
Phase 3, Not yet recruiting, NCT06961721, clinicaltrials.gov, 16 Oct 2026
In the full profile
- Owner and partners2
- Trials5
- Evidence for its targets1
- Competitors3
- Signals1
Every asset’s record: target, stage, trials and the evidence behind it.